In a young healthy man with an isolated episode of hematospermia and a normal physical exam, is an ultrasound indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ultrasound for Isolated Hematospermia in a Young Man

In a young healthy man under 40 years of age with a single episode of hematospermia and a normal physical exam, ultrasound is NOT indicated—watchful waiting with reassurance is the appropriate management. 1

Clinical Approach by Age and Presentation

Men Under 40 Years with Transient/Episodic Hematospermia

  • No imaging is recommended for this population because hematospermia is typically a benign, self-limited condition that resolves spontaneously within several weeks. 1, 2

  • The ACR Appropriateness Criteria assigns transrectal ultrasound (TRUS) a rating of 3 ("usually not appropriate") for men under 40 with transient hematospermia and no other symptoms. 1

  • Watchful waiting, reassurance, and routine clinical evaluation suffice in the absence of risk factors such as history of cancer, known urogenital malformation, bleeding disorders, or associated symptoms. 1, 3

  • Initial workup should be limited to:

    • Visual confirmation that blood originates from the patient's ejaculate (not postcoital bleeding from partner) 1, 2
    • Urinalysis and urine culture 1
    • Semen analysis 1
    • Complete blood count and coagulation studies 1
    • Testing for sexually transmitted infections if lower urinary tract symptoms are present 3
  • When a cause is identified in men under 40, urogenital infection accounts for 40-55% of cases, making this the most common identifiable etiology. 2, 3

When Imaging BECOMES Indicated (Any Age)

TRUS is the first-line imaging modality (rated 8, "usually appropriate") in the following scenarios: 1

  • Age ≥40 years (regardless of symptom duration) 1
  • Persistent or recurrent hematospermia at any age (beyond several weeks) 1, 2
  • Associated symptoms or signs of disease including: 1
    • Fever, chills, weight loss, bone pain
    • Lower urinary tract symptoms (dysuria, frequency)
    • Abnormal digital rectal examination
    • New non-reducible varicocele (red flag requiring immediate workup) 2

TRUS Performance Characteristics

  • TRUS demonstrates abnormalities in 82-95% of men with hematospermia, though many findings (prostatic calcifications, benign prostatic hyperplasia, non-obstructing cysts) may be incidental age-related changes rather than the true cause. 1, 4, 5

  • Common TRUS findings include: 1, 4

    • Calcifications or calculi in prostate, ejaculatory ducts, or seminal vesicles
    • Seminal vesicle, ejaculatory duct, or prostatic cysts
    • Prostatitis or seminal vesiculitis
    • Benign prostatic hyperplasia (age-related)

MRI as Second-Line Imaging

  • MRI is indicated when TRUS is negative or inconclusive (rated 7-8, "usually appropriate"). 1

  • MRI advantages over TRUS: 1, 6

    • Operator-independent acquisition
    • Superior soft-tissue contrast
    • Multiplanar high-resolution anatomic evaluation
    • Better characterization of midline/paramedian cysts' organ of origin
    • More accurate assessment of ejaculatory duct obstruction
    • Superior delineation of hemorrhage location and age within seminal tract

Critical Age-Based Screening Requirement

  • All men ≥40 years with hematospermia MUST undergo prostate cancer screening with PSA testing and digital rectal examination, even when another apparent cause (such as recent prostate biopsy) is identified. 1, 2, 3

  • In the study by Han et al., all 8 malignancies (3.0% of 270 patients) occurred exclusively in men over 40 years old, underscoring the importance of age-stratified evaluation. 5

Common Pitfalls to Avoid

  • Do not order imaging in young men (<40) with isolated transient hematospermia—this adds unnecessary anxiety, cost, and may reveal incidental findings of unclear significance. 1, 2

  • Do not skip PSA testing in men ≥40 years even when an obvious benign cause seems present, as malignancy can coexist. 2

  • Do not assume prostatic calcifications or benign prostatic hyperplasia are causative—these are often incidental age-related findings in asymptomatic men. 1, 2

  • Confirm the blood is truly from the patient's ejaculate rather than postcoital bleeding from a sexual partner before initiating any workup. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Differential Diagnosis of Hematospermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Evaluation and treatment of hematospermia.

American family physician, 2009

Research

Hematospermia Evaluation at MR Imaging.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2016

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.